Relationship of generalized anxiety symptoms to urinary 5-hydroxyindoleacetic acid and vanillylmandelic acid
| Autor: | Catherine Woodman, Michael J. Garvey, Cindy Laukes, Russell Noyes |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
Adult
Male Serotonin medicine.medical_specialty Generalized anxiety disorder Personality Inventory Metabolite Norepinephrine Vanilmandelic Acid chemistry.chemical_compound Internal medicine medicine Humans Vanillylmandelic acid Biological Psychiatry 5-Hydroxyindoleacetic acid Hydroxyindoleacetic Acid Middle Aged medicine.disease Anxiety Disorders Psychiatry and Mental health Endocrinology nervous system chemistry Anxiety Female medicine.symptom Arousal Psychology Anxiety disorder medicine.drug |
| Zdroj: | Psychiatry Research. 57:1-5 |
| ISSN: | 0165-1781 |
| DOI: | 10.1016/0165-1781(94)02510-p |
| Popis: | Urinary levels of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) and the norepinephrine metabolite vanillylmandelic acid (VMA) were measured in 45 patients with generalized anxiety disorder. Multiple regression analysis demonstrated that the severity of several anxiety symptoms was predicted by levels of 5-HIAA and VMA. These data are consistent with the proposal that serotonin and norepinephrine may be involved in the pathophysiology of anxiety. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect